Skip to main content
Quoin Pharmaceuticals, Ltd. logo

Quoin Pharmaceuticals, Ltd. — Investor Relations & Filings

Ticker · QNRX ISIN · US74907L1026 US Manufacturing
Filings indexed 540 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US QNRX

About Quoin Pharmaceuticals, Ltd.

https://quoinpharma.com/

Quoin Pharmaceuticals, Ltd. is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare and orphan diseases. The company's lead product candidate, QRX003, is in development for the treatment of Netherton Syndrome, a rare hereditary skin disorder. Quoin utilizes the proprietary Invisicare delivery technology, for which it holds exclusive rights for orphan rare skin disease applications. The company's strategy involves establishing exclusive international marketing and distribution partnerships to augment its own commercial infrastructure in the US, Europe, and Japan, ensuring its products reach patients globally.

Recent filings

Filing Released Lang Actions
10-Q - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer)
Interim / Quarterly Report
2026-05-07 English
10-K - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer)
Annual Report FY 2025
2026-03-26 English
8-K - Quoin Pharmaceuticals, Ltd. (0001671502) (Filer)
Regulatory Filings
2026-03-26 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.